Sign in
4

Changes in Ownership

Vanda Pharmaceuticals Inc. Filed Acc 0001209191-18-002067

SVP & Chief Commercial Officer acquired 20,000 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I In the form
Reverberi Gian Piero SVP & Chief Commercial Officer 2018-01-02 Option exercise +12,500 87,500 D
Reverberi Gian Piero SVP & Chief Commercial Officer 2018-01-02 Option exercise +7,500 110,000 D
Derivatives
Reverberi Gian Piero SVP & Chief Commercial Officer 2018-01-02 Option exercise · Restricted Stock Unit −12,500 25,000 D
Reverberi Gian Piero SVP & Chief Commercial Officer 2018-01-02 Option exercise · Restricted Stock Unit −7,500 15,000 D
Loading xslF345X03/doc4.xml…